Davidson Charles E's Form 4 filing
Nephros Inc (NEPH) · filed Sep 16, 2026
- Accession no.
- 0001398344-26-017120
- Filed
- Sep 16, 2026, 5:05 PM ET
- Trade date
- Sep 14, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Davidson Charles ECIK 0001001391 | 10% Owner |
| Wexford Capital LPCIK 0001048462 | 10% Owner |
| Jacobs JosephCIK 0001048485 | 10% Owner |
| Wexford GP LLCCIK 0001472112 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Common Stock | JOtherDisposed | −3,355,111 | $0.00 | $0 | 189,377 | Indirect | |
| Sep 14, 2026 | Common Stock | JOtherDisposed | −22,710 | $3.95 | −$89,704.5 | 166,667 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.